Tranexamic Acid in Postoperative Patients
For postoperative bleeding, administer tranexamic acid 1 gram IV as early as possible, with cumulative doses kept below 50 mg/kg per 24 hours to minimize seizure risk, while avoiding use in patients with active thrombosis, subarachnoid hemorrhage, or severe renal impairment.
Recommended Dosing by Clinical Context
Post-Cardiac Surgery
Strongly recommend TXA use in bleeding patients post-cardiac surgery 1. The evidence demonstrates high certainty that TXA reduces bleeding volume (mean reduction 268 mL), need for reoperation (RR 0.53), and transfusion requirements (RR 0.67) 1.
- Standard dose: 1 gram IV initially
- Critical threshold: Keep total dose <50 mg/kg per 24 hours (<4 g/24h for average adult)
- Infusion rate: Maximum 1 mL/minute to prevent hypotension 2
Postpartum Hemorrhage
Administer 1 gram IV immediately when postpartum hemorrhage is identified 3, 1.
- Time-critical window: Must give within 3 hours of bleeding onset
- Efficacy decreases 10% for every 15-minute delay 3
- No benefit and potential harm after 3 hours 3
- This represents a broader indication than previous recommendations, now including all causes of postpartum hemorrhage, not just trauma 3
Orthopedic Surgery (Hip/Knee Arthroplasty)
Evidence supports preoperative dosing, though additional postoperative doses beyond a single perioperative dose show no additional benefit 4.
- Preoperative: 10-15 mg/kg IV (or 1 g) before incision 5
- Alternative: Topical TXA >2 g appears more efficacious than lower topical doses 6
- No increased venous thromboembolism risk demonstrated in this population 6
Trauma with Hemorrhagic Shock
For life-threatening hemorrhage, particularly with hemorrhagic shock:
- Single dose: 1-2 grams (15-30 mg/kg) IV 7
- Timing: As early as possible, ideally within first 90 minutes post-trauma 7
- Pre-hospital administration is appropriate when indicated 7
Dose Adjustments for Renal Impairment
Critical consideration: TXA accumulates in renal dysfunction, increasing seizure risk 2, 8.
| Serum Creatinine | Adjusted Dose |
|---|---|
| 1.36-2.83 mg/dL | 10 mg/kg twice daily |
| 2.83-5.66 mg/dL | 10 mg/kg once daily |
| >5.66 mg/dL | 10 mg/kg every 48h OR 5 mg/kg every 24h |
Absolute Contraindications
Do not administer TXA in these situations 2:
- Active intravascular clotting/DIC
- Subarachnoid hemorrhage (risk of cerebral edema and infarction)
- Known hypersensitivity to tranexamic acid
- History of thromboembolic event during current pregnancy (for obstetric use) 3
Relative Contraindications & Cautions
Exercise heightened caution in 2:
- History of seizures (TXA is proconvulsant)
- Cardiovascular disease history (though not absolute contraindication)
- Concurrent prothrombotic medications: Factor IX concentrates, anti-inhibitor coagulant concentrates, hormonal contraceptives 2
Safety Profile & Adverse Events
Seizure Risk
The most significant dose-dependent adverse effect 1, 8, 9:
- Incidence: <1% at recommended doses
- Risk factors: High cumulative doses (>50 mg/kg), advanced age, renal dysfunction, cardiac surgery with prolonged bypass 8
- High-dose single administration significantly increases seizure risk (OR 6.66) 9
- Consider EEG monitoring in high-risk patients 2
Thromboembolic Events
The evidence shows small absolute increases 1:
- DVT: RR 2.10 (absolute increase 0.2%)
- PE: RR 1.78 (absolute increase 0.3%)
- Dose-dependent: Marked increase at 4 grams (HR 5.33) 7
- In patients without shock: Absolute thromboembolic risk difference ranges from -0.2% to +4% 7
Important nuance: Multiple high-quality studies in cardiac and orthopedic surgery show no increased symptomatic VTE when used at recommended doses 1, 6, 9.
Route of Administration
Intravenous only for systemic effect 2.
- Never administer intrathecally - serious adverse reactions including seizures and cardiac arrhythmias have occurred with inadvertent neuraxial administration 2
- Clearly label syringes with IV route 2
- Topical application reduces local bleeding but does not reduce transfusion rates as effectively as IV administration 9
Key Clinical Pitfalls
- Delayed administration: Efficacy is time-dependent, particularly in trauma and postpartum hemorrhage
- Excessive dosing in cardiac surgery: Historical use of doses up to 10-fold higher than recommended contributed to seizure reports 1
- Ignoring renal function: Failure to adjust for renal impairment increases seizure risk
- Route confusion: Ensure IV-only administration; never neuraxial
- Infusion rate: Rapid infusion causes hypotension; maintain ≤1 mL/minute 2